Medtronic plc vs Abbvie Inc.
MDT vs ABBV — side-by-side comparison from reported financials. MDT leads 6, ABBV leads 4 of 10 comparable metrics.
Medtronic plc
MDT · Healthcare
$88.01+0.30%Mixed
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | MDT | ABBV |
|---|---|---|
| Price | $88.01 | $276.43 |
| Market cap | $113B | $488B |
| Revenue (TTM) | $37.5B | $64.4B |
| Revenue growth | +5.2% | +1.8% |
| Net margin | 13.9% | 9.8% |
| Free cash flow | $6.13B | $18.2B |
| Net cash (debt) | — | ($56.2B) |
| 1-year price return | -8.8% | +19.8% |
| P/E | 21.6 | 77.4 |
| P/E vs own history (cheap-side %) | 96% | 23% |
| Dividend yield | 3.22% | 2.45% |
| Return on equity | 11% | 96% |
| Altman Z-score | — | 2.33 |
| CV checks passed | 10 of 11 | 9 of 11 |
| Employees | 95,000 | 57,000 |
Full résumé-style profiles: MDT CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.